Top

Quality of Life Research

Published in:

Open Access 01-02-2022 | Hypertension

Reference data among general population and known-groups validity among hypertensive population of the EQ-5D-5L in Vietnam

Authors: Vu Quynh Mai, Kim Bao Giang, Hoang Van Minh, Lars Lindholm, Sun Sun, Klas Göran Sahlen

Published in: Quality of Life Research | Issue 2/2022

Abstract

Purpose

This study aims to provide EQ-5D-5L population norms among the general population in Vietnam and to test EQ-5D-5L’ construction validity among people living with hypertension there.

Methods

Descriptive statistics of the five dimensions and five levels, EQ-VAS and EQ-5D-5L indexes were categorised into gender and age groups for the EQ-5D-5L population norms. Known-groups testing was set for lower EQ-5D-5L outcomes among people who were aware of their hypertensive status, females, people with more comorbidities, less education, older ages, and higher body mass indexes. Level of confident interval was 95%.

Results

The mean EQ-VAS and EQ-5D-5L indexes were 81.10 (SD: 13.35) and 0.94 (SD: 0.09) among the general population. The EQ-5D-5L outcomes were better among younger people, males, people with more education, employees, and single people. Respondents reported fewer problems with self-care and usual activities and tend to have problems at higher levels across older ages. The known-group testing showed statistically significant results. The mean EQ-VAS and EQ-5D-5L indexes of people in the diagnosed hypertensive group (71.48 and 0.94, respectively) were statistically significantly smaller than they were in the non-hypertensive and undiagnosed hypertensive group (76.65 and 0.97; 76.95 and 0.96 accordingly). Statistically significant associations of lower EQ-5D-5L indexes and EQ-VAS were found among people diagnosed for hypertension, people suffering from an incremental comorbidity, and obese people.

Conclusion

This study has provided EQ-5D-5L population norms for the general population and evidence for known-groups validity of the EQ-5D-5L instrument among hypertensive people in Vietnam.

Available only for authorised users

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 - The Lancet. (n.d.). Retrieved May 21, 2021, from https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)61766-8/fulltext

Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., … Murray, C. J. L. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222https://doi.org/10.1016/S0140-6736(20)30925-9

Ministry of Health, General Department of Preventive Medicine. (2015). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic National survey on the risk factors of non-communicable diseases (STEPS) Viet Nam, 2015.

Hoang, V. M., Tran, Q. B., Vu, T. H. L., Nguyen, T. K. N., Kim, B. G., Pham, Q. N., … Tran, D. P. (2019). Patterns of Raised Blood Pressure in Vietnam: Findings from the WHO STEPS Survey 2015. International Journal of Hypertension. Research Article. https://doi.org/10.1155/2019/1219783

Vietnam Ministry of Health, Health Partnership Group,. (2015). Joint Annual Health Review Report - 2015: Strengthening primary health care at the grassroots towards universal health coverage. Vietnam.

Ministry of Health. Circular 30/2018/TT-BYT on Promulgation of list of modern medicines, biologicals, radiopharmaceuticals and tracers covered by health insurance, insurance coverage ratio and payment conditions thereof. , 30/2018/TT-BYT 30/2018/TT-BYT § Annex 1.

Ministry of Health. Decision 5315/QD-BYT on the principles and criteria for the formulation of list of new drugs under the national health insurance scheme, Code 5315/QD-BYT/2018 (enacted date: 31/08/2018).

Vietnam Ministry of Health, Health Partnership Group,. (2014). Joint Annual Health Review Report - 2014: Strengthening prevention and control of non-communicable disease.

Drummond, M. F. (1987). Resource allocation decisions in health care: A role for quality of life assessments? Journal of Chronic Diseases, 40(6), 605–616. https://doi.org/10.1016/0021-9681(87)90021-XCrossRefPubMed

10.

Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the Economic Evaluation of Health Care Programmes (4th ed.). Oxford University Press.

11.

NICE. (2013). Guide to the methods of technology appraisal 2013 in UK. Retrieved February 4, 2020, from https://www.nice.org.uk/process/pmg9/chapter/foreword

12.

CADTH,. (2015, December 2). Guidelines for the Economic Evaluation of Health Technologies: Canada. CADTH.ca. Retrieved February 4, 2020, from https://www.cadth.ca/about-cadth/how-we-do-it/methods-and-guidelines/guidelines-for-the-economic-evaluation-of-health-technologies-canada

13.

Teerawattananon, Y., & Chaikledkaew, U. (2008). Thai health technology assessment guideline development. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet, 91 Suppl 2, S11–15.

14.

Mai, V. Q., Sun, S., Minh, H. V., Luo, N., Giang, K. B., Lindholm, L., & Sahlen, K. G. (2020). An EQ-5D-5L value set for vietnam. Quality of Life Research. https://doi.org/10.1007/s11136-020-02469-7CrossRefPubMedPubMedCentral

15.

Janssen, B., & Szende, A. (2014). Population norms for the EQ-5D. In A. Szende, B. Janssen, & J. Cabases (Eds.), Self-reported population health: An International Perspective based on EQ-5D. Springer.

16.

Golicki, D., & Niewada, M. (2017). EQ-5D-5L Polish population norms. Archives of Medical Science : AMS, 13(1), 191–200. https://doi.org/10.5114/aoms.2015.52126CrossRefPubMed

17.

Bailey, H., Janssen, M. F., La Foucade, A., & Kind, P. (2019). EQ-5D-5L population norms and health inequalities for Trinidad and Tobago. PLoS ONE, 14(4), e0214283. https://doi.org/10.1371/journal.pone.0214283CrossRefPubMedPubMedCentral

18.

McCaffrey, N., Kaambwa, B., Currow, D. C., & Ratcliffe, J. (2016). Health-related quality of life measured using the EQ-5D-5L: South Australian population norms. Health and Quality of Life Outcomes, 14(1), 133. https://doi.org/10.1186/s12955-016-0537-0CrossRefPubMedPubMedCentral

19.

Garcia-Gordillo, M. A., Adsuar, J. C., & Olivares, P. R. (2016). Normative values of EQ-5D-5L: In a Spanish representative population sample from Spanish Health Survey, 2011. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 25(5), 1313–1321. https://doi.org/10.1007/s11136-015-1164-7CrossRef

20.

Encheva, M., Djambazov, S., Vekov, T., & Golicki, D. (2020). EQ-5D-5L Bulgarian population norms. The European journal of health economics: HEPAC: Health economics in prevention and care, 21(8), 1169–1178. https://doi.org/10.1007/s10198-020-01225-5CrossRefPubMed

21.

Health Quality Council of Alberta. (2016). EQ-5D-5L index norms for Alberta population. Retrieved from https://www.hqca.ca/wp-content/uploads/2018/05/HQCA_EQ_5D_AB_Norms_Report_Addendum_DRAFT___June_28.pdf

22.

Prevolnik Rupel, V., & Ogorevc, M. (2020). EQ-5D-5L Slovenian population norms. Health and Quality of Life Outcomes, 18(1), 333. https://doi.org/10.1186/s12955-020-01584-wCrossRefPubMedPubMedCentral

23.

Yang, Z., Busschbach, J., Liu, G., & Luo, N. (2018). EQ-5D-5L norms for the urban Chinese population in China. Health and Quality of Life Outcomes, 16(1), 210. https://doi.org/10.1186/s12955-018-1036-2CrossRefPubMedPubMedCentral

24.

Shiroiwa, T., Fukuda, T., Ikeda, S., Igarashi, A., Noto, S., Saito, S., & Shimozuma, K. (2016). Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 25(3), 707–719. https://doi.org/10.1007/s11136-015-1108-2CrossRef

25.

Wong, E.L.-Y., Cheung, A.W.-L., Wong, A.Y.-K., Xu, R. H., Ramos-Goñi, J. M., & Rivero-Arias, O. (2019). Normative profile of health-related quality of life for Hong Kong general population using preference-based instrument EQ-5D-5L. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 22(8), 916–924. https://doi.org/10.1016/j.jval.2019.02.014CrossRef

26.

Purba, F. D., Hunfeld, J. A. M., Iskandarsyah, A., Fitriana, T. S., Sadarjoen, S. S., Passchier, J., & Busschbach, J. J. V. (2018). Quality of life of the Indonesian general population: Test-retest reliability and population norms of the EQ-5D-5L and WHOQOL-BREF. PLoS ONE, 13(5), e0197098. https://doi.org/10.1371/journal.pone.0197098CrossRefPubMedPubMedCentral

27.

Emrani, Z., Akbari Sari, A., Zeraati, H., Olyaeemanesh, A., & Daroudi, R. (2020). Health-related quality of life measured using the EQ-5D-5L: Population norms for the capital of Iran. Health and Quality of Life Outcomes, 18(1), 108. https://doi.org/10.1186/s12955-020-01365-5CrossRefPubMedPubMedCentral

28.

Vaingankar, J. A., Subramaniam, M., Tan, L. W. L., Abdin, E., Lim, W. Y., Wee, H. L., … van Dam, R. M. (2018). Psychometric properties and population norms of the positive mental health instrument in a representative multi-ethnic Asian population. BMC Medical Research Methodology, 18(1), 29https://doi.org/10.1186/s12874-018-0487-9

29.

Nguyen, L. H., Tran, B. X., Le Hoang, Q., & N., Tran, T. T., & Latkin, C. A. . (2017). Quality of life profile of general Vietnamese population using EQ-5D-5L. Health and Quality of Life Outcomes, 15(1), 199. https://doi.org/10.1186/s12955-017-0771-0CrossRefPubMedPubMedCentral

30.

Rencz, F., Lakatos, P. L., Gulácsi, L., Brodszky, V., Kürti, Z., Lovas, S., … Palatka, K. (2019). Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 28(1), 141–152https://doi.org/10.1007/s11136-018-2003-4

31.

Nolan, C. M., Longworth, L., Lord, J., Canavan, J. L., Jones, S. E., Kon, S. S. C., & Man, W.D.-C. (2016). The EQ-5D-5L health status questionnaire in COPD: Validity, responsiveness and minimum important difference. Thorax, 71(6), 493–500. https://doi.org/10.1136/thoraxjnl-2015-207782CrossRefPubMed

32.

Cheung, P. W. H., Wong, C. K. H., Samartzis, D., Luk, K. D. K., Lam, C. L. K., Cheung, K. M. C., & Cheung, J. P. Y. (2016). Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis. Scoliosis and Spinal Disorders, 11, 19. https://doi.org/10.1186/s13013-016-0083-xCrossRefPubMedPubMedCentral

33.

Bilbao, A., García-Pérez, L., Arenaza, J. C., García, I., Ariza-Cardiel, G., Trujillo-Martín, E., & Martín-Fernández, J. (2018). Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: Reliability, validity and responsiveness. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 27(11), 2897–2908https://doi.org/10.1007/s11136-018-1929-x

34.

Koh, D., Abdullah, A. M. K. B., Wang, P., Lin, N., & Luo, N. (2016). Validation of Brunei’s Malay EQ-5D questionnaire in patients with Type 2 diabetes. PLoS ONE, 11(11), e0165555. https://doi.org/10.1371/journal.pone.0165555CrossRefPubMedPubMedCentral

35.

Purba, F. D., Hunfeld, J. A. M., Timman, R., Iskandarsyah, A., Fitriana, T. S., Sadarjoen, S. S., Passchier, J., Busschbach, J. J. V. (2018). Test-retest reliability of EQ-5D-5L valuation techniques: the composite time trade-off and discrete choice experiments. Value in Health, 21(10), 1243–1249. https://doi.org/10.1016/j.jval.2018.02.003CrossRef

36.

Golicki, D., Niewada, M., Buczek, J., Karliñska,, A., Kobayashi, A., Janssen, M. F., & Pickard, A. S. (2015). Validity of EQ-5D-5L in stroke. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 24(4), 845–850. https://doi.org/10.1007/s11136-014-0834-1CrossRef

37.

Sakthong, P., Sonsa-Ardjit, N., Sukarnjanaset, P., & Munpan, W. (2015). Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 24(12), 3015–3022. https://doi.org/10.1007/s11136-015-1038-zCrossRef

38.

Tran, B. X., Ohinmaa, A., & Nguyen, L. T. (2012). Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health and Quality of Life Outcomes, 10, 132. https://doi.org/10.1186/1477-7525-10-132CrossRefPubMedPubMedCentral

39.

Nguyen, T. N. P., Hoang, V. M., Tran, T. N., Shellaby, J. T., Adler, A. J., McGuire, H., … Do, V. V. (2020). Knowledge change related to hypertension in the Southern province of Vietnam: a community based, before and after intervention evaluation. Journal of Global Health Science, 2(1), e14. https://doi.org/10.35500/jghs.2020.2.e14

40.

Ministry of Health. National guidline for commune health center in diagnosis and treatment of Hypertension. , No 3192/QD-BYT No 3192/QD-BYT (2010). Retrieved from https://kcb.vn/wp-content/uploads/2015/07/huong_dan_chan_doan_dieu_tri_tha.pdf

41.

Janssen, B., Szende, A., & Ramos-Goñi, J. M. (2014). Data and methods. In A. Szende, B. Janssen, & J. Cabases (Eds.), Self-reported population health: An International Perspective based on EQ-5D. Springer.

42.

Ye, R., Liu, K., Zhang, Z., Gong, S., & Chen, X. (2018). Health-related quality of life of hypertension in China: A systematic review and meta-analysis. Journal of Cardiovascular Medicine. https://doi.org/10.2459/JCM.0000000000000678CrossRefPubMed

43.

Bao, X.-Y., Xie, Y.-X., Zhang, X.-X., Peng, X., Huang, J.-X., Du, Q.-F., & Wang, P.-X. (2019). The association between multimorbidity and health-related quality of life: A cross-sectional survey among community middle-aged and elderly residents in southern China. Health and Quality of Life Outcomes. https://doi.org/10.1186/s12955-019-1175-0CrossRefPubMedPubMedCentral

44.

Khalifeh, M., Salameh, P., Hajje, A. A., Awada, S., Rachidi, S., & Bawab, W. (2015). Hypertension in the Lebanese adults: Impact on health related quality of life. Journal of Epidemiology and Global Health, 5(4), 327–336. https://doi.org/10.1016/j.jegh.2015.02.003CrossRefPubMedPubMedCentral

45.

Korhonen, P. E., Kivelä, S.-L., Kautiainen, H., Järvenpää, S., & Kantola, I. (2011). Health-related quality of life and awareness of hypertension. Journal of Hypertension, 29(11), 2070–2074. https://doi.org/10.1097/HJH.0b013e32834bbca7CrossRefPubMed

46.

Mi, B., Dang, S., Li, Q., Zhao, Y., Yang, R., Wang, D., & Yan, H. (2015). Association between awareness of hypertension and health-related quality of life in a cross-sectional population-based study in rural area of Northwest China. Medicine, 94(29), e1206. https://doi.org/10.1097/MD.0000000000001206CrossRefPubMedPubMedCentral

47.

World Health Organization. (n.d.). A global brief on hypertension: Silent killer, global public health crisis (No. WHO/DCO/WHD/2013/2). Retrieved from https://apps.who.int/iris/handle/10665/79059

48.

Riley, E., Chang, J., Park, C., Kim, S., & Song, I. (2019). Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population. Clinical Drug Investigation, 39(9), 899–908. https://doi.org/10.1007/s40261-019-00814-4CrossRefPubMed

49.

Zhang, L., Guo, X., Zhang, J., Chen, X., Zhou, C., Ge, D., & Qian, Y. (2017). Health-related quality of life among adults with and without hypertension: A population-based survey using EQ-5D in Shandong China. Scientific Reports. https://doi.org/10.1038/s41598-017-15083-4CrossRefPubMedPubMedCentral

50.

Mena-Martin, F. J., Martin-Escudero, J. C., Simal-Blanco, F., Carretero-Ares, J. L., Arzua-Mouronte, D., & Herreros-Fernandez, V. (2003). Health-related quality of life of subjects with known and unknown hypertension: Results from the population-based Hortega study. Journal of Hypertension, 21(7), 1283–1289. https://doi.org/10.1097/00004872-200307000-00015CrossRefPubMed

51.

Vu, H. M., Nguyen, L. H., Tran, T. H., Pham, K. T. H., Phan, H. T., Nguyen, H. N., … Ho, R. C. M. (2019). Effects of Chronic Comorbidities on the Health-Related Quality of Life among Older Patients after Falls in *Vietnamese Hospitals. International Journal of Environmental Research and Public Health, 16(19). https://doi.org/10.3390/ijerph16193623

52.

Nguyen, T.-P.-L., Krabbe, P. F. M., Nguyen, T.-B.-Y., Schuiling-Veninga, C. C. M., Wright, E. P., & Postma, M. J. (2015). Utilities of Patients with Hypertension in Northern Vietnam. PLoS ONE, 10(10), e0139560. https://doi.org/10.1371/journal.pone.0139560CrossRefPubMedPubMedCentral

53.

Bang, K.-S., Tak, S. H., Oh, J., Yi, J., Yu, S.-Y., & Trung, T. Q. (2017). Health Status and the Demand for Healthcare among the Elderly in the Rural Quoc-Oai District of Hanoi in Vietnam. BioMed Research International. https://doi.org/10.1155/2017/4830968CrossRefPubMedPubMedCentral

Title: Reference data among general population and known-groups validity among hypertensive population of the EQ-5D-5L in Vietnam
Authors: Vu Quynh Mai
Kim Bao Giang
Hoang Van Minh
Lars Lindholm
Sun Sun
Klas Göran Sahlen
Publication date: 01-02-2022
Publisher: Springer International Publishing
Keywords: Hypertension
Hypertension
Published in: Quality of Life Research / Issue 2/2022
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-021-02959-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Reference data among general population and known-groups validity among hypertensive population of the EQ-5D-5L in Vietnam

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2022

Screening for symptoms of anxiety and depression in patients treated with renal replacement therapy: utility of the Edmonton Symptom Assessment System-Revised

Feasibility and performance of smartphone-based daily micro-surveys among patients recovering from cancer surgery

Response shift after coronary revascularization

The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force

Belgian population norms for the EQ-5D-5L, 2018

Health utilities in pediatric cancer patients and survivors: a systematic review and meta-analysis for clinical implementation